Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis [0.03%]
布地奈德维持治疗显微性结肠炎的疗效及安全性系统评价和 meta 分析
June Tome,Raseen Tariq,Leslie C Hassett et al.
June Tome et al.
Background: Microscopic colitis (MC) is a common cause of chronic diarrhea. Randomized controlled trials (RCTs) have demonstrated the efficacy of budesonide treatment for MC. However, relapse is frequent after discontinua...
Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration [0.03%]
炎症性肠病时代谢疗法的审批周期：欧洲药品管理局与美国食品药品监督管理局对比
Jurij Hanzel,Christopher Ma,Theshani Amalka De Silva et al.
Jurij Hanzel et al.
Cannabis Use in IBD Is Associated With Increased Healthcare Utilization but not With Surgery or Death [0.03%]
大麻的使用与炎症性肠病患者增加的就医次数有关，但不增加手术和死亡风险
Lauren Loeb,Jami Kinnucan
Lauren Loeb
The Impact of Cannabis Use on Clinical Outcomes in Inflammatory Bowel Disease: A Population-based Longitudinal Cohort Study [0.03%]
大麻使用对炎症性肠病临床结局的影响：一项基于人群的纵向队列研究
Danny Glickman,Shannon Dalessio,Wesley M Raup-Konsavage et al.
Danny Glickman et al.
Background: Cannabis use is common in inflammatory bowel disease (IBD). Recent studies demonstrated that use of cannabis may relieve symptoms; however, it is still unclear how safe cannabis and its derivatives are for IBD...
Inflammatory Bowel Disease and Risk of Global Cardiovascular Diseases and Type 2 Diabetes [0.03%]
炎症性肠病与全身心血管疾病和2型糖尿病风险的关系
Zhengbao Zhu,Yiming Jia,Fu-Rong Li et al.
Zhengbao Zhu et al.
Background: Inflammatory bowel disease (IBD) was associated with elevated risk of cardiometabolic diseases in observational studies. We aimed to evaluate the observational and genetic associations of Crohn's disease (CD) ...
Postvaccination Symptoms After SARS-CoV-2 mRNA Vaccination Among Patients With Inflammatory Bowel Disease: A Prospective, Comparative Study [0.03%]
炎症性肠病患者接种新型冠状病毒mRNA疫苗后的不良反应：一项前瞻性比较研究
Angela Mujukian,Rashmi Kumar,Dalin Li et al.
Angela Mujukian et al.
Background: Vaccine hesitancy is prevalent among people with IBD, in part due to insufficient evidence regarding comparative safety of vaccines in this population. ...
Disease Clearance as a New Outcome in Ulcerative Colitis: a Systematic Review and Expert Consensus [0.03%]
ulcerative colitis治愈达标的新结局：系统性回顾与专家共识
Ferdinando D&#x;Amico,Fernando Magro,Britta Siegmund et al.
Ferdinando D&#x;Amico et al.
The concept of disease clearance has been proposed as a potential target in ulcerative colitis (UC). We conducted a systematic review to investigate the role of disease clearance, defined as a composite outcome including simultaneous clinic...
Real-Life Efficacy of Tofacitinib in Various Situations in Ulcerative Colitis: A Retrospective Worldwide Multicenter Collaborative Study [0.03%]
托法替尼治疗溃疡性结肠炎的现实世界有效性：一项回顾性的全球多中心合作研究
Tamás Resál,Péter Bacsur,Csilla Keresztes et al.
Tamás Resál et al.
Background and aims: Tofacitinib (TFB) appears to be effective in the treatment of ulcerative colitis (UC); however, available real-world studies are limited by cohort size. TFB could be an option in the treatment of acut...
Multicenter Study
Inflammatory bowel diseases. 2024 May 2;30(5):768-779. DOI:10.1093/ibd/izad135 2024
Ulcerative Colitis Is Associated With Diet-related Inflammation and Physical Activity in the IBD Partners E-cohort [0.03%]
溃疡性结肠炎与炎症性肠病合作伙伴E队列中的饮食相关炎症和体育活动有关
Kelli E DuBois,Christine E Blake,Caroline Rudisill et al.
Kelli E DuBois et al.
Background: Individuals with ulcerative colitis (UC) seek complementary treatment methods, including diet and physical activity, to manage the burden of living with UC. This study examined associations between diet-associ...
GPR120/FFAR4: A Potential New Therapeutic Target for Inflammatory Bowel Disease [0.03%]
GPR120/FFAR4可能是治疗炎症性肠病的潜在新靶点
Amalia Di Petrillo,Amit Kumar,Sara Onali et al.
Amalia Di Petrillo et al.
Inflammatory bowel disease, whose major forms are Crohn's disease and ulcerative colitis, is characterized by chronic inflammation of the gut due to the loss of tolerance toward antigens normally contained in the gut lumen. G protein-couple...